Leverage our continuous innovative respiratory solutions including devices, software, integrated endpoint collection, and proactive risk-based monitoring support

Leverage our continuous innovative respiratory solutions including devices, software, integrated endpoint collection, and proactive risk-based monitoring support

ERT is at the forefront of innovative respiratory solutions for clinical trials. Developing new technologies and services enables us to deliver superior data quality that sponsors demand while simplifying research for investigative sites.

MasterScope™ – The all-in-one respiratory and multi-endpoint platform

MasterScope™ optimizes your cardiopulmonary trials:

  • Integrates Spirometry, 12-lead ECG, Patient Reported Outcomes/eDiary, and FeNO in one high performance system
  • Customizable, protocol-specific workflows to simplify the most complex of trials — with multi-language user interface option only available from ERT
  • Software designed with sites in mind at every step for better performance (including smart control for loop selection/deselection and enforced patient rest time)
  • The only diagnostic platform with biometric user identification to comply with 21 CFR Part 11 and maintain quality
  • Unique Multi-protocol option that allows one device to support multiple studies
  • Automatic, secure data transfers optimizes centralized overread and device software updates, ensuring latest protocol amendments are in use

MasterScope™ – The all-in-one respiratory and multi-endpoint platform

MasterScope™ optimizes your cardiopulmonary trials:

  • Integrates Spirometry, 12-lead ECG, COA/Patient Reported Outcomes, and FeNO in one high performance system
  • Customizable, protocol-specific workflows to simplify the most complex of trials
  • Software designed with sites in mind at every step for better performance (including smart control for loop selection/deselection and enforced patient rest time)
  • The only diagnostic platform with biometric user identification to comply with 21 CFR Part 11 and maintain quality
  •  Unique multi-protocol option that allows one device to support multiple studies
  • Automatic, secure data transfers optimizes centralized overread and device software updates, ensuring latest protocol amendments are in use

AM3® and AM3® GSM – Home Monitoring made easy

AM3® is an integrated, easy-to-use home spirometer and eDiary for clinical trials that delivers for your study and patients:

  • Measures and saves all relevant expiratory flow volume parameters such as PEF and FEV1
  • Records symptoms, events and medication, including severity and dose – a complete electronic diary for patient home monitoring
  • Stores all data in non-volatile memory
  • Makes data collection painless with web upload and GSM global text messaging transmission options, all transmitted securely to ERT’s EXPERT® Central private cloud platform
  • Offers EXACT-PRO, ACQ, and BCSS questionnaires for Patient Reported Outcomes / Clinical Outcome Assessments (COAs)

Centralized Data Surveillance of Respiratory Safety Studies to Support Risk-Based Monitoring

As regulatory guidance and interest in Risk-Based Monitoring goes mainstream, ERT stands ready with technology and systems to support early, proactive trending of site performance in ERT respiratory trials. With focused data oversight activities on risks related to quality, critical subject safety, and trial integrity, ERT offers a customizable Centralized Surveillance solution to address cardiopulmonary data quality threats and deliver time-tested mitigation interventions to underperforming sites. This data is available in scheduled reports or integrated into your EDC and other eClinical systems in near real-time, and the solution provides sponsors and CROs with more meaningful, intelligible insights for actionable, accurate decision-making. Centralized Surveillance with ERT improves data integrity, patient safety, and trial success, as well as yields considerable time and cost savings.

AM3® and AM3® GSM – Home Monitoring made easy

AM3® is an integrated, easy-to-use home spirometer and eDiary for clinical trials that delivers for your study and patients:

PEF Meter and eDiary for Clinical Trials
  • Measures and saves all relevant expiratory flow volume parameters such as PEF and FEV1
  • Records symptoms, events and medication, including severity and dose – a complete electronic diary for patient home monitoring
  • Stores all data in non-volatile memory
  • Makes data collection painless with web upload and GSM global text messaging transmission options, all transmitted securely to ERT’s EXPERT® Central private cloud platform
  • Offers EXACT-PRO, ACQ, and BCSS questionnaires for Patient Reported Outcomes / Clinical Outcome Assessments (COAs)

Supported by our EXPERT® Central platform, sites love My Study Portal: Real-time data, simplified tasks and maximum study ROI

Centralized Data Surveillance of Respiratory Safety Studies to Support Risk-Based Monitoring

As regulatory guidance and interest in Risk-Based Monitoring goes mainstream, ERT stands ready with technology and systems to support early, proactive trending of site performance in ERT respiratory trials. With focused data oversight activities on risks related to quality, critical subject safety, and trial integrity, ERT offers a customizable Centralized Data Surveillance solution to address cardiopulmonary data quality threats and deliver time-tested mitigation interventions to underperforming sites. This data provides sponsors and CROs with more meaningful, intelligible insights for actionable, accurate decision-making. Centralized Data Surveillance with ERT improves data integrity, patient safety and trial success, as well as yields considerable time and cost savings.

Metrics Champion Consortium Best Practices

mcclogo

Today’s drug development industry is under increased pressure to improve its research and development performance and strategies by reducing timelines and costs while at the same time dramatically increasing productivity and maintaining quality. Biotechnology and pharmaceutical organizations that achieve efficient clinical trial cycle times attribute their success to maintaining focus on core competencies, prioritizing resource utilization, and outsourcing services. ERT is a member of the Metrics Champion Consortium (MCC), the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. We collect Key Performance Indicators (KPIs) on a daily, monthly and quarterly basis, enabling us to continue to improve our processes and overall performance. As a member of the MCC Metric Committee, ERT fully supports the collection and reporting of MCC metrics for cardiopulmonary trials.

Metrics Champion Consortium Best Practices

mcclogo

ERT is a member of the Metrics Champion Consortium (MCC), the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. We collect Key Performance Indicators (KPIs) on a daily, monthly and quarterly basis, enabling us to continue to improve our processes and overall performance. As a member of the MCC Metric Committee, ERT fully supports the collection and reporting of MCC metrics for cardiopulmonary trials.